Skip to content

Clinical trials

Phase 2 Cardiotoxicity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiotoxicity Phase: Phase 2 Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20062
20071
20091
20102
20111
20121
20142
20162
20181
20191
20223
20234
20241
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated9
Completed7
Recruiting5
Unknown status5
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Washington University School of Medicine2
AHS Cancer Control Alberta1
Alexandria University1
Avera McKennan Hospital & University Health Center1
Beth Israel Deaconess Medical Center1
Catharina Ziekenhuis Eindhoven1
Cedars-Sinai Medical Center1
Fondazione IRCCS Policlinico San Matteo di Pavia1
GERCOR - Multidisciplinary Oncology Cooperative Group1
Hawler Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiotoxicity27
Breast Neoplasms16
Heart Failure3
Lymphoma3
Neoplasms3
Sarcoma3
Breast Neoplasms, Male2
Neoplasm Metastasis2
Radiation Injuries2
Carbon Monoxide Poisoning1

Trials

Showing 76 to 27 of 27. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.